The Motley Fool

NYSE:ZYME (Zymeworks Inc.)

$35.98 $0.79 (0.02) Thursday, November 14, 2019 at 4:00:00 p.m. Eastern Standard Time

About

Last updated Nov 14, 2019, 04:00:00pm EST
Current Price $35.98
Today's Change $0.79 (2.2%)
Close Price $35.19
Open Price $35.22
Bid $35.93
Ask $35.98
Day Range $35.00 - $36.31
Year Range $13.96 - $36.88
Volume 35,664
Average Volume 281,811
Market Cap $1,386,466,504.00
EPS (ttm) $-1.82

Related Articles

3 Hot Stocks to Buy in October

Markets are reeling, but investors should still look to add stocks like Zymeworks Inc (TSX:ZYME)(NYSE:ZYME) right now. More »

These Were the Worst-Performing Stocks on the TSX Last Week

Markets keep rising, but there are bargains to be had. Learn more about beaten-down stocks like Imperial Metals Corp (TSX:III), Zymeworks Inc (TSX:ZYME)(NYSE:ZYME), and... More »

3 Top TSX Stocks for the Future

Investors gearing up for the future should target stocks like Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and others. More »

3 Top Canadian Pharma Stocks for Ambitious Investors

Pharma stocks like Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) are coming into their own, offering growth investors a lot of upside potential. More »

3 BioPharm Stocks Yielding 100% Yearly Returns

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME), among other Canadian biopharmaceutical companies, has been hit with shorter supplies and rising demand. More »

3 Top Canadian Healthcare Stocks for Growth Investors

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and two other healthcare stocks may have flown under the radar of recession-proofing investors. More »

This 2017 IPO Still Boasts Massive Growth Potential

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) stock has nearly doubled from its IPO price in 2017, and the biotech’s product candidates should really excite investors. More »

Alert! 2 High-Growth Stocks to Buy Before 2020

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and Stars Group Inc. (TSX:TSGI)(NASDAQ:TSG) are well-positioned to benefit from big growth in their respective markets. More »

Top 2 TSX Healthcare Stocks to Buy in June

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and BELLUS Health Inc. (TSX:BLU) offer huge potential in the burgeoning healthcare sector. More »

This High-Growth Biopharma Stock Just Got Some Great News

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) just saw a top product candidate hit a milestone. This is a growth stock to hold onto into the 2020s. More »